Supplemental Material for The Dog as a Second Species for Toxicology Testing Provides Value to Drug Development by Nancy Bower, William E. Achanzar, Virginie Boulifard, Peter R. Brinck, Birgit Kittel, and John L. Vahle in International Journal of Toxicology</p
During the development of potential new medicines or agrochemicals, an assessment of the safety prof...
This Article is brought to you for free and open access by the Articles, Studies, and Book Chapters ...
Dogs remain the main non-rodent species in preclinical drug development. Despite the current dearth ...
The objective of the pharmaceutical industry is to develop new drugs that are safe for human use. In...
Supplemental Material, DS1_IJT_10.1177_1091581819827232 for Language Consideration and Methodologica...
Supplemental material for Informing efficient pilot development of animal trauma models through qual...
1 The preclinical animal safety testing strategy used in pharmaceutical development is generally suc...
Supplemental Material for Transparency in Non-Technical Project Summaries to Promote the Three Rs in...
Supplemental Material, Risk_Assessment_Form for Development of an Occupational Risk Assessment Tool ...
<p>Supplemental material for Environmental enrichment prevents pup mortality in laboratory mice by C...
Supplemental Material, DS1_VET_10.1177_0300985818789466 for Cutaneous Tumors in Swiss Dogs: Retrospe...
Dogs are sometimes referred to as “man’s best friend” and with the increase in urbanization and life...
Supplemental Material, DS1_VET_10.1177_0300985819843683 for Aging and Senescence in Canine Testes by...
Dogs are sometimes referred to as “man’s best friend” and with the increase in urbanization and life...
Supplemental material for Guidelines for porcine models of human bacterial infections by Louise K Je...
During the development of potential new medicines or agrochemicals, an assessment of the safety prof...
This Article is brought to you for free and open access by the Articles, Studies, and Book Chapters ...
Dogs remain the main non-rodent species in preclinical drug development. Despite the current dearth ...
The objective of the pharmaceutical industry is to develop new drugs that are safe for human use. In...
Supplemental Material, DS1_IJT_10.1177_1091581819827232 for Language Consideration and Methodologica...
Supplemental material for Informing efficient pilot development of animal trauma models through qual...
1 The preclinical animal safety testing strategy used in pharmaceutical development is generally suc...
Supplemental Material for Transparency in Non-Technical Project Summaries to Promote the Three Rs in...
Supplemental Material, Risk_Assessment_Form for Development of an Occupational Risk Assessment Tool ...
<p>Supplemental material for Environmental enrichment prevents pup mortality in laboratory mice by C...
Supplemental Material, DS1_VET_10.1177_0300985818789466 for Cutaneous Tumors in Swiss Dogs: Retrospe...
Dogs are sometimes referred to as “man’s best friend” and with the increase in urbanization and life...
Supplemental Material, DS1_VET_10.1177_0300985819843683 for Aging and Senescence in Canine Testes by...
Dogs are sometimes referred to as “man’s best friend” and with the increase in urbanization and life...
Supplemental material for Guidelines for porcine models of human bacterial infections by Louise K Je...
During the development of potential new medicines or agrochemicals, an assessment of the safety prof...
This Article is brought to you for free and open access by the Articles, Studies, and Book Chapters ...
Dogs remain the main non-rodent species in preclinical drug development. Despite the current dearth ...